BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 36871280)

  • 1. Signaling pathways that regulate adaptive β-cell proliferation for the treatment of diabetes.
    Shirakawa J
    J Diabetes Investig; 2023 Jun; 14(6):735-740. PubMed ID: 36871280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin Signaling Regulates the FoxM1/PLK1/CENP-A Pathway to Promote Adaptive Pancreatic β Cell Proliferation.
    Shirakawa J; Fernandez M; Takatani T; El Ouaamari A; Jungtrakoon P; Okawa ER; Zhang W; Yi P; Doria A; Kulkarni RN
    Cell Metab; 2017 Apr; 25(4):868-882.e5. PubMed ID: 28286049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Newer perspective on the coupling between glucose-mediated signaling and β-cell functionality.
    Shirakawa J; Terauchi Y
    Endocr J; 2020 Jan; 67(1):1-8. PubMed ID: 31694991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. E2F1 transcription factor mediates a link between fat and islets to promote β cell proliferation in response to acute insulin resistance.
    Shirakawa J; Togashi Y; Basile G; Okuyama T; Inoue R; Fernandez M; Kyohara M; De Jesus DF; Goto N; Zhang W; Tsuno T; Kin T; Pan H; Dreyfuss JM; Shapiro AMJ; Yi P; Terauchi Y; Kulkarni RN
    Cell Rep; 2022 Oct; 41(1):111436. PubMed ID: 36198264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Luseogliflozin increases beta cell proliferation through humoral factors that activate an insulin receptor- and IGF-1 receptor-independent pathway.
    Shirakawa J; Tajima K; Okuyama T; Kyohara M; Togashi Y; De Jesus DF; Basile G; Kin T; Shapiro AMJ; Kulkarni RN; Terauchi Y
    Diabetologia; 2020 Mar; 63(3):577-587. PubMed ID: 31897526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wild-type offspring of heterozygous prolactin receptor-null female mice have maladaptive β-cell responses during pregnancy.
    Huang C
    J Physiol; 2013 Mar; 591(5):1325-38. PubMed ID: 23247113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuronal signals regulate obesity induced β-cell proliferation by FoxM1 dependent mechanism.
    Yamamoto J; Imai J; Izumi T; Takahashi H; Kawana Y; Takahashi K; Kodama S; Kaneko K; Gao J; Uno K; Sawada S; Asano T; Kalinichenko VV; Susaki EA; Kanzaki M; Ueda HR; Ishigaki Y; Yamada T; Katagiri H
    Nat Commun; 2017 Dec; 8(1):1930. PubMed ID: 29208957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PKCζ Is Essential for Pancreatic β-Cell Replication During Insulin Resistance by Regulating mTOR and Cyclin-D2.
    Lakshmipathi J; Alvarez-Perez JC; Rosselot C; Casinelli GP; Stamateris RE; Rausell-Palamos F; O'Donnell CP; Vasavada RC; Scott DK; Alonso LC; Garcia-Ocaña A
    Diabetes; 2016 May; 65(5):1283-96. PubMed ID: 26868297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age-dependent human β cell proliferation induced by glucagon-like peptide 1 and calcineurin signaling.
    Dai C; Hang Y; Shostak A; Poffenberger G; Hart N; Prasad N; Phillips N; Levy SE; Greiner DL; Shultz LD; Bottino R; Kim SK; Powers AC
    J Clin Invest; 2017 Oct; 127(10):3835-3844. PubMed ID: 28920919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FoxO1 Plays an Important Role in Regulating β-Cell Compensation for Insulin Resistance in Male Mice.
    Zhang T; Kim DH; Xiao X; Lee S; Gong Z; Muzumdar R; Calabuig-Navarro V; Yamauchi J; Harashima H; Wang R; Bottino R; Alvarez-Perez JC; Garcia-Ocaña A; Gittes G; Dong HH
    Endocrinology; 2016 Mar; 157(3):1055-70. PubMed ID: 26727107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crucial role of insulin receptor substrate-2 in compensatory beta-cell hyperplasia in response to high fat diet-induced insulin resistance.
    Takamoto I; Terauchi Y; Kubota N; Ohsugi M; Ueki K; Kadowaki T
    Diabetes Obes Metab; 2008 Nov; 10 Suppl 4():147-56. PubMed ID: 18834442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidermal growth factor receptor signaling promotes pancreatic β-cell proliferation in response to nutrient excess in rats through mTOR and FOXM1.
    Zarrouki B; Benterki I; Fontés G; Peyot ML; Seda O; Prentki M; Poitout V
    Diabetes; 2014 Mar; 63(3):982-93. PubMed ID: 24194502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fate of the beta-cell in the pathophysiology of type 2 diabetes.
    Campbell RK
    J Am Pharm Assoc (2003); 2009; 49 Suppl 1():S10-5. PubMed ID: 19801360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatocyte growth factor plays a key role in insulin resistance-associated compensatory mechanisms.
    Araújo TG; Oliveira AG; Carvalho BM; Guadagnini D; Protzek AO; Carvalheira JB; Boschero AC; Saad MJ
    Endocrinology; 2012 Dec; 153(12):5760-9. PubMed ID: 23024263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gestational Diabetes Mellitus From Inactivation of Prolactin Receptor and MafB in Islet β-Cells.
    Banerjee RR; Cyphert HA; Walker EM; Chakravarthy H; Peiris H; Gu X; Liu Y; Conrad E; Goodrich L; Stein RW; Kim SK
    Diabetes; 2016 Aug; 65(8):2331-41. PubMed ID: 27217483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cigarette smoke exposure impairs β-cell function through activation of oxidative stress and ceramide accumulation.
    Tong X; Chaudhry Z; Lee CC; Bone RN; Kanojia S; Maddatu J; Sohn P; Weaver SA; Robertson MA; Petrache I; Evans-Molina C; Kono T
    Mol Metab; 2020 Jul; 37():100975. PubMed ID: 32283079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The required beta cell research for improving treatment of type 2 diabetes.
    Thorens B
    J Intern Med; 2013 Sep; 274(3):203-14. PubMed ID: 23751050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metallothionein 1 negatively regulates glucose-stimulated insulin secretion and is differentially expressed in conditions of beta cell compensation and failure in mice and humans.
    Bensellam M; Shi YC; Chan JY; Laybutt DR; Chae H; Abou-Samra M; Pappas EG; Thomas HE; Gilon P; Jonas JC
    Diabetologia; 2019 Dec; 62(12):2273-2286. PubMed ID: 31624901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of Beta-Cell Apoptosis in Type 2 Diabetes-Prone Situations and Potential Protection by GLP-1-Based Therapies.
    Costes S; Bertrand G; Ravier MA
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34069914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of β-cell function: a translational journey from the bench to the bedside.
    Goldfine AB; Kulkarni RN
    Diabetes Obes Metab; 2012 Oct; 14 Suppl 3():152-60. PubMed ID: 22928576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.